KR880009015A - 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 - Google Patents

알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 Download PDF

Info

Publication number
KR880009015A
KR880009015A KR1019880000504A KR880000504A KR880009015A KR 880009015 A KR880009015 A KR 880009015A KR 1019880000504 A KR1019880000504 A KR 1019880000504A KR 880000504 A KR880000504 A KR 880000504A KR 880009015 A KR880009015 A KR 880009015A
Authority
KR
South Korea
Prior art keywords
formula
alkyl
allyl
pharmaceutically acceptable
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019880000504A
Other languages
English (en)
Korean (ko)
Inventor
세나핑거 칼
베이에를 루디
본 헬무트
쥬스트 멜리타
니츠 롤프-에베르하트
Original Assignee
한스-게오르그 우르바흐, 한스 유흐너
카젤라 아크티엔게젤샤트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한스-게오르그 우르바흐, 한스 유흐너, 카젤라 아크티엔게젤샤트 filed Critical 한스-게오르그 우르바흐, 한스 유흐너
Publication of KR880009015A publication Critical patent/KR880009015A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019880000504A 1987-01-24 1988-01-23 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도 Ceased KR880009015A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3702083.8 1987-01-24
DE19873702083 DE3702083A1 (de) 1987-01-24 1987-01-24 Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
KR880009015A true KR880009015A (ko) 1988-09-13

Family

ID=6319474

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880000504A Ceased KR880009015A (ko) 1987-01-24 1988-01-23 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도

Country Status (13)

Country Link
US (1) US4888333A (enExample)
EP (1) EP0276710B1 (enExample)
JP (1) JPS63201177A (enExample)
KR (1) KR880009015A (enExample)
AT (1) ATE70837T1 (enExample)
CA (1) CA1309408C (enExample)
DE (2) DE3702083A1 (enExample)
DK (1) DK640687A (enExample)
ES (1) ES2038700T3 (enExample)
GR (1) GR3003738T3 (enExample)
HU (1) HU203331B (enExample)
PH (1) PH24709A (enExample)
ZA (1) ZA88446B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702083A1 (de) * 1987-01-24 1988-08-04 Cassella Ag Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
US5221680A (en) * 1988-01-14 1993-06-22 Cassella Aktiengesellschaft Substituted 3-aminosydnonimines
DE3800830A1 (de) * 1988-01-14 1989-07-27 Cassella Ag Substituierte 3-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4015236A1 (de) * 1990-05-13 1991-11-14 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3820210A1 (de) * 1988-06-14 1989-12-21 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921460A1 (de) * 1989-06-30 1991-01-03 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4028679A1 (de) * 1990-09-10 1992-03-19 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4031373A1 (de) * 1990-10-04 1992-04-09 Cassella Ag 3-piperazino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
WO1993018767A1 (de) * 1992-03-24 1993-09-30 Cassella Aktiengesellschaft Verwendung von sydnoniminen zur behandlung erektiler dysfunktionen
WO1998047896A1 (en) * 1997-04-22 1998-10-29 Chugai Seiyaku Kabushiki Kaisha Sydononimine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) * 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3107933A1 (de) * 1981-03-02 1982-09-16 Cassella Ag, 6000 Frankfurt Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
JPS5859977A (ja) * 1981-10-06 1983-04-09 Banyu Pharmaceut Co Ltd 新規なn−アシルシドノンイミン誘導体およびその製法
DE3526068A1 (de) * 1985-07-20 1987-01-22 Cassella Ag Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische praeparate
DE3702083A1 (de) * 1987-01-24 1988-08-04 Cassella Ag Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
DE3702083A1 (de) 1988-08-04
HU203331B (en) 1991-07-29
GR3003738T3 (enExample) 1993-03-16
ES2038700T3 (es) 1993-08-01
EP0276710A1 (de) 1988-08-03
CA1309408C (en) 1992-10-27
ZA88446B (en) 1988-07-22
US4888333A (en) 1989-12-19
DK640687A (da) 1988-06-25
PH24709A (en) 1990-10-01
EP0276710B1 (de) 1991-12-27
HUT50142A (en) 1989-12-28
JPS63201177A (ja) 1988-08-19
DK640687D0 (da) 1987-12-07
DE3867073D1 (de) 1992-02-06
ATE70837T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
KR880002834A (ko) α-알킬-4-아미노-3-퀴놀린메탄올 및 1-(4-아르알킬아미노-3-퀴놀리닐) 알칸온, 이의 제조방법 및 약제로서의 용도
ES2040373T3 (es) Esteroides puenteados en 19,11beta, su preparacion y preparados farmaceuticos que contienen estos compuestos.
KR940011475A (ko) 신규한 에리트로마이신 유도체, 그의 제조 방법 및 의약으로서의 그의 용도
KR890013035A (ko) 인돌로카르바졸 유도체와 그 제조방법 및 그들을 함유하는 약제조성물
KR920003968A (ko) 염증성 장 질환의 치료방법
ATE63124T1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
KR880009015A (ko) 알리머켑토아세틸시드논이민, 이의 제조방법 및 이의 용도
KR960007592A (ko) 신규한 피롤로카바졸
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
KR930007914A (ko) 제1위치에 에테르 또는 티오에테르 그룹을 함유하는 프탈라진 및 이의 제조방법
KR910000607A (ko) 새로운 에스테르
KR950703557A (ko) 약제로서 사용되는 헤테로아릴 화합물(Heteroaryl Compounds Used as Pharmaceuticals)
PT93126A (pt) Processo para a preparacao de eteres carboxialquilicos da 2-amino-7- -hidroxitetralina
KR900700098A (ko) 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체
KR920007995A (ko) 벤즈아미드 유도체
KR930006003A (ko) 이미다졸릴메틸-피리딘류 화합물
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
ES8205224A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos.
RU94002313A (ru) Эфирные производные гексагидронафталина, их получение и фармацевтическая композиция на их основе
KR970706825A (ko) 헬리코박터의 감염에 기인하는 질환의 치료제(remedy for diseases caused by infection with helicobacter)
ATE70838T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
DK247389D0 (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
KR840004728A (ko) 제초제로써 사용되는 피라졸 유도체의 제조방법
US3635971A (en) 3 (3 4-dihydro-3-oxo-2-quinoxalinyl) propionamides

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880123

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19921224

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19880123

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19951023

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19960215

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19951023

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I